Literature DB >> 12640452

A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.

Mark O'Driscoll1, Victor L Ruiz-Perez, C Geoffrey Woods, Penny A Jeggo, Judith A Goodship.   

Abstract

Seckel syndrome (OMIM 210600) is an autosomal recessive disorder characterized by intrauterine growth retardation, dwarfism, microcephaly and mental retardation. Clinically, Seckel syndrome shares features in common with disorders involving impaired DNA-damage responses, such as Nijmegen breakage syndrome (OMIM 251260) and LIG4 syndrome (OMIM 606593). We previously mapped a locus associated with Seckel syndrome to chromosome 3q22.1-q24 in two consanguineous Pakistani families. Further marker analysis in the families, including a recently born unaffected child with a recombination in the critical region, narrowed the region to an interval of 5 Mbp between markers D3S1316 and D3S1557 (145.29 Mbp and 150.37 Mbp). The gene encoding ataxia-telangiectasia and Rad3-related protein (ATR) maps to this region. A fibroblast cell line derived from an affected individual displays a defective DNA damage response caused by impaired ATR function. We identified a synonymous mutation in affected individuals that alters ATR splicing. The mutation confers a phenotype including marked microcephaly (head circumference 12 s.d. below the mean) and dwarfism (5 s.d. below the mean). Our analysis shows that UV-induced ATR activation can occur in non-replicating cells following processing by nucleotide excision repair.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640452     DOI: 10.1038/ng1129

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  325 in total

1.  A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein.

Authors:  Nicolas Foray; Didier Marot; Anastasia Gabriel; Voahangy Randrianarison; Antony M Carr; Michel Perricaudet; Alan Ashworth; Penny Jeggo
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

2.  Molecular cross-talk among chromosome fragility syndromes.

Authors:  Jordi Surrallés; Stephen P Jackson; Maria Jasin; Michael B Kastan; Stephen C West; Hans Joenje
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

Review 3.  Interplay between DNA replication, recombination and repair based on the structure of RecG helicase.

Authors:  Geoffrey S Briggs; Akeel A Mahdi; Geoffrey R Weller; Qin Wen; Robert G Lloyd
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-01-29       Impact factor: 6.237

4.  Thresholds of replication stress signaling in cancer development and treatment.

Authors:  Jiri Bartek; Martin Mistrik; Jirina Bartkova
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

5.  ATM-dependent phosphorylation of the checkpoint clamp regulates repair pathways and maintains genomic stability.

Authors:  Min Hwa Shin; Ming Yuan; Hao Zhang; Joseph B Margolick; Mihoko Kai
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

6.  Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.

Authors:  Atsushi Shibata; Olivia Barton; Angela T Noon; Kirsten Dahm; Dorothee Deckbar; Aaron A Goodarzi; Markus Löbrich; Penny A Jeggo
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

7.  E2F1 localizes to sites of UV-induced DNA damage to enhance nucleotide excision repair.

Authors:  Ruifeng Guo; Jie Chen; Feng Zhu; Anup K Biswas; Thomas R Berton; David L Mitchell; David G Johnson
Journal:  J Biol Chem       Date:  2010-04-22       Impact factor: 5.157

Review 8.  DNA damage response.

Authors:  Giuseppina Giglia-Mari; Angelika Zotter; Wim Vermeulen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

9.  S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde.

Authors:  Victor Chun-Lam Wong; Haley L Cash; Jessica L Morse; Shan Lu; Anatoly Zhitkovich
Journal:  Cell Cycle       Date:  2012-07-01       Impact factor: 4.534

Review 10.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.